Table 3.
Observed and expected number of non-AIDS-defining cancers (NADCs) and all-cause deaths in patients with HIV compared with the general population in Japan
| Cancer type | Observed | Expected | SIR (95% CI) |
|---|---|---|---|
| Liver | 9 | 1.9 | 4.7 (2.1–8.2) |
| Colorectal | 15 | 7.7 | 1.9 (1.1–3.0) |
| Colon | 10 | 4.7 | 2.1 (1.0–3.7) |
| Anorectal* | 5 | 3.1 | 1.6 (0.5–3.4) |
| Gastric | 11 | 6.0 | 1.8 (1.0–3.1) |
| Lung | 8 | 4.4 | 1.8 (0.8–3.3) |
| Oral cavity and pharynx | 3 | 1.0 | 2.9 (0.5–7.0) |
| Esophageal | 2 | 1.4 | 1.4 (0.1–4.0) |
| Pancreas | 1 | 1.2 | 0.8 (< 0.1–3.3) |
| Biliary tract | 2 | 0.6 | 3.2 (0.3–9.2) |
| Bladder | 2 | 0.8 | 2.4 (0.2–6.7) |
| Skin | 1 | 0.6 | 1.8 (< 0.1–6.9) |
| Prostate | 1 | 4.0 | 0.2 (< 0.1–1.0) |
| Thyroid | 1 | 0.6 | 1.7 (< 0.1–6.5) |
| Breast | 1 | 0.8 | 1.3 (< 0.1–5.0) |
| Hodgkin lymphoma | 4 | NAa | NAa |
Note. *Anorectal cancer included rectal cancer (n = 2) and anal cancer (n = 3). aGeneral population data were not available for Hodgkin lymphoma
Abbreviation Standardized incidence ratio, SIR standardized mortality ratio